(+)-Doxapram

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug Name(+)-Doxapram
Drug Alias Name多沙普仑GAL-054
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNitric oxide donors
TargetsPotassium channel subfamily K member 3Potassium channel subfamily K member 9
Therapy Area/IndicationsAnesthesia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySaudi Arabia
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGalleon
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKing Faisal University
Active IndicationsN/A
Inactive IndicationsAnesthesia

Other Information

ATC CodeN/A
Related LinksN/A